Analysis was created to detect head and neck cancer at an early stage 13:11

Scientists of the University of Michigan formed a new blood test for early detection of the head and neck malignant tumors of the head and neck caused by the human papillomavirus (HPV). About it reported On the website of the scientific institution – Michigan University (UMICH).

Development is called MyHPVSCORE. According to scientists, without the need to do invasive procedures, throat, larynx, nasopharynx, nose or salivary glands to detect cancer was the first example of the species.

The test is based on the detection of the tumor DNA circulating in the blood, which makes it possible to correct the presence of the disease long before the symptoms begin.

The first clinical laboratory using new technology began to work in the autumn of 2024 and gradually increased volumes by processing dozens of examples a day. According to the president of the project, Dr. Jay Chad Brenner, the laboratory, was created in response to the increasing demand of patients for fast and accurate diagnostic methods. He also said there were no authorinolarengological departments equipped with similar laboratory capabilities in the United States.

Development also allows doctors to evaluate the effectiveness of the treatment more accurately and define the recurrence of the disease at the earliest stages – even before visual changes and a deterioration of the well. This is particularly important for patients with weakened immunity in a high -risk group.

Scientists remembered that HPV could be infected with the close contact of the skin and mucous membranes. In most cases, HPV is sexually transmitted. Proteins that control HPV “close” to protection of cells from damage and encourage them to divide uncontrollably, which increases the risk of cancer tumors.

Previously, scientists learnedFruits from Nigeria can become a new weapon in the fight against cancer.